Our AI-driven insights, real-time analytics, and agile promotion tools help you break free from static planning cycles. You can accelerate new-to-brand (NTB) growth and optimize performance throughout the product lifecycle, evolving your strategy as fast as your market.
Our solution helps you operationalize smarter decisions for your brand. By unifying agile execution, launch strategy, real-time intelligence, and AI-driven insights, you gain the foresight to drive performance and outpace the competition, ensuring you're always one step ahead.
Reimagine what’s possible with the NTB Forecast methodology. You can now achieve over 90% accuracy versus the 50% industry average, ensuring your launch planning and decisions are both data-driven and fully defensible to stakeholder.
Our advanced analytics, forecasting, and launch advisory solutions deliver measurable results for pharmaceutical companies. These validated outcomes demonstrate our commitment to precision, speed, and commercial success across critical business functions.
Brand Optimizer combines AI-powered capabilities with unparalleled evidence and operational guidance to create a holistic framework. It focuses on patient acquisition and retention, and unlike separate, siloed analyses, it provides a comprehensive, actionable impact assessment that helps you make confident, data-driven decisions.
Our approach is unique because IQVIA combines unmatched data depth with AI-powered analytics across over 300 million anonymized patients and 30,000+ HCP data sources. We integrate strategy development, real-time execution, and performance measurement into one connected platform, ensuring seamless coordination and efficiency across the entire product lifecycle."
NTB Forecast delivers over 90% accuracy for new launch brands and over 95% for in-market brands throughout the entire product lifecycle. Unlike traditional, reactive forecasts, our unique methodology focuses on patient acquisition dynamics, directly linking promotional investments to sales optimization for superior outcomes and growth.
The BrandImpact™ score is the industry's only metric linking field activity to prescribing behavior at scale. Built from 11 key performance indicators and cross-validated against real-world prescription data, it provides you with a clear 'FICO score' for your brand's overall promotional impact and effectiveness.
IQVIA’s ProVoice captures direct prescriber feedback, giving your brand unbiased, real-world insights into the complex HCP decision-making process. These invaluable insights help you to accurately measure promotional impact, refine your brand messaging, and optimize your engagement strategies with confidence.